Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details 3)

v3.23.1
Summary of Significant Accounting Policies (Details 3) - shares
 3 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,720,584 1,422,251    
Employee Stock Option 1 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents     301,391 37,641
Warrant 1 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents     2,419,193 1,384,610